Michael Hamblin

ORCID iD
https://orcid.org/0000-0001-6431-4605
  • Keywords
  • Show details Hide details
photomedicine,

Sources:
Michael Hamblin (2017-10-13)

photobiomodulation,

Sources:
Michael Hamblin (2017-10-13)

photodynamic therapy,

Sources:
Michael Hamblin (2017-10-13)

new photosensitizers,

Sources:
Michael Hamblin (2017-10-13)

antimicrobial photodynamic inactivation,

Sources:
Michael Hamblin (2017-10-13)

nanomedicine,

Sources:
Michael Hamblin (2017-10-13)

drug delivery

Sources:
Michael Hamblin (2017-10-13)

  • Websites
  • Show details Hide details
homepage

Sources:
Michael Hamblin (2017-10-13)

amazon author page

Sources:
Michael Hamblin (2017-10-13)

DFHCC

Sources:
Michael Hamblin (2017-10-13)

Mendeley profile

Sources:
Elsevier - Mendeley (2017-11-24)

  • Other IDs
  • Show details Hide details
Scopus Author ID: 7004296356

Sources:
Scopus - Elsevier (2013-06-29)

Scopus Author ID: 55942123300

Sources:
Scopus - Elsevier (2017-07-25)

Biography

Michael R Hamblin Ph.D. is a Principal Investigator at Wellman Center for Photomedicine, Massachusetts General Hospital, and an Associate Professor Harvard Medical School. He has interests in photodynamic therapy and photobiomodulation. He has published 402 peer-reviewed articles, is Editor/Associate Editor for 10 journals and serves on NIH Study-Sections. He has an h-factor 87 and >29,500 citations. He has authored/edited 23 textbooks on PDT and photomedicine including SPIE proceedings. Dr Hamblin was elected as a Fellow of SPIE in 2011, received 1st Endre Mester Lifetime Achievement Award Photomedicine from NAALT in 2017, and Outstanding Career Award from Dose Response Society in 2018.
No publications added yet